Healthcare provider profile · identity verified

Heather Taylor Lackey, NP

Nurse Practitioner · RALEIGH, NC · NPI 1023673993

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	360	53
Trazodone Hcl	Trazodone Hcl	287	49
Furosemide	Furosemide	269	57
Omeprazole	Omeprazole	247	43
Gabapentin	Gabapentin	200	38
Pantoprazole Sodium	Pantoprazole Sodium	189	36
Potassium Chloride	Potassium Chloride	186	37
Tramadol Hcl	Tramadol Hcl	167	43
Trulicity	Dulaglutide	167	11
Buspirone Hcl	Buspirone Hcl	161	24
Eliquis	Apixaban	160	30
Sertraline Hcl	Sertraline Hcl	157	34
Lorazepam	Lorazepam	156	46
Levothyroxine Sodium	Levothyroxine Sodium	149	27
Amlodipine Besylate	Amlodipine Besylate	148	34
Tamsulosin Hcl	Tamsulosin Hcl	139	24
Memantine Hcl	Memantine Hcl	138	20
Escitalopram Oxalate	Escitalopram Oxalate	136	20
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	124	34
Metoprolol Tartrate	Metoprolol Tartrate	106	19
Oxycodone Hcl	Oxycodone Hcl	106	28
Metoprolol Succinate	Metoprolol Succinate	104	17
Mirtazapine	Mirtazapine	101	24
Lisinopril	Lisinopril	92	20
Carvedilol	Carvedilol	89	19
Divalproex Sodium	Divalproex Sodium	89	16
Losartan Potassium	Losartan Potassium	89	17
Jardiance	Empagliflozin	86	12
Duloxetine Hcl	Duloxetine Hcl	84	15
Ondansetron Hcl	Ondansetron Hcl	83	31
Famotidine	Famotidine	82	19
Pregabalin	Pregabalin	82	15
Sucralfate	Sucralfate	81	13
Rivastigmine	Rivastigmine Tartrate	77	suppressed
Donepezil Hcl	Donepezil Hcl	68	suppressed
Citalopram Hbr	Citalopram Hydrobromide	62	suppressed
Baclofen	Baclofen	59	13
Tizanidine Hcl	Tizanidine Hcl	58	suppressed
Albuterol Sulfate	Albuterol Sulfate	56	26
Quetiapine Fumarate	Quetiapine Fumarate	52	suppressed
Finasteride	Finasteride	50	suppressed
Levetiracetam	Levetiracetam	49	11
Metformin Hcl	Metformin Hcl	49	suppressed
Prednisone	Prednisone	49	38
Torsemide	Torsemide	49	12
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	47	15
Clonazepam	Clonazepam	46	suppressed
Clopidogrel	Clopidogrel Bisulfate	46	12
Spironolactone	Spironolactone	46	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	45	suppressed
Diclofenac Sodium	Diclofenac Sodium	45	18
Fluticasone Propionate	Fluticasone Propionate	45	28
Myrbetriq	Mirabegron	44	suppressed
Warfarin Sodium	Warfarin Sodium	42	suppressed
Januvia	Sitagliptin Phosphate	40	suppressed
Alprazolam	Alprazolam	37	suppressed
Benztropine Mesylate	Benztropine Mesylate	36	suppressed
Allopurinol	Allopurinol	35	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	35	suppressed
Meloxicam	Meloxicam	35	suppressed
Lamotrigine	Lamotrigine	34	suppressed
Ipratropium-Albuterol	Ipratropium/Albuterol Sulfate	32	19
Carbidopa-Levodopa	Carbidopa/Levodopa	30	suppressed
Risperidone	Risperidone	29	suppressed
Diltiazem Hcl	Diltiazem Hcl	28	suppressed
Ropinirole Hcl	Ropinirole Hcl	28	suppressed
Dapagliflozin	Dapagliflozin Propanediol	27	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	27	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	27	suppressed
Pravastatin Sodium	Pravastatin Sodium	27	suppressed
Albuterol Sulfate Hfa	Albuterol Sulfate	25	12
Olanzapine	Olanzapine	25	suppressed
Divalproex Sodium Er	Divalproex Sodium	24	suppressed
Farxiga	Dapagliflozin Propanediol	24	suppressed
Trihexyphenidyl Hcl	Trihexyphenidyl Hcl	24	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	23	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	23	suppressed
Metformin Hcl Er	Metformin Hcl	23	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	23	suppressed
Lacosamide	Lacosamide	22	suppressed
Medroxyprogesterone Acetate	Medroxyprogesterone Acetate	22	suppressed
Insulin Lispro	Insulin Lispro	21	suppressed
Nystatin	Nystatin	21	16
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	21	19
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	18
Ciprofloxacin Hcl	Ciprofloxacin Hcl	20	17
Doxycycline Hyclate	Doxycycline Hyclate	19	18
Fluconazole	Fluconazole	19	14
Aripiprazole	Aripiprazole	18	suppressed
Bupropion Xl	Bupropion Hcl	18	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	18	12
Topiramate	Topiramate	18	suppressed
Ceftriaxone	Ceftriaxone Sodium	17	15
Insulin Lispro Kwikpen U-100	Insulin Lispro	17	suppressed
Mirabegron Er	Mirabegron	17	suppressed
Phenobarbital	Phenobarbital	17	suppressed
Valsartan	Valsartan	17	suppressed
Ondansetron Odt	Ondansetron	16	13
Rosuvastatin Calcium	Rosuvastatin Calcium	16	suppressed
Bupropion Hcl	Bupropion Hcl	15	suppressed
Glipizide	Glipizide	15	suppressed
Lactulose	Lactulose	15	suppressed
Montelukast Sodium	Montelukast Sodium	15	suppressed
Venlafaxine Hcl	Venlafaxine Hcl	15	suppressed
Entresto	Sacubitril/Valsartan	13	suppressed
Methenamine Hippurate	Methenamine Hippurate	13	suppressed
Azithromycin	Azithromycin	12	suppressed
Doxepin Hcl	Doxepin Hcl	12	suppressed
Fesoterodine Fumarate Er	Fesoterodine Fumarate	12	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	12	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	12	suppressed
Lovastatin	Lovastatin	12	suppressed
Morphine Sulfate	Morphine Sulfate	12	suppressed
Hydralazine Hcl	Hydralazine Hcl	11	suppressed
Irbesartan	Irbesartan	11	suppressed
Levofloxacin	Levofloxacin	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	suppressed
Paroxetine Hcl	Paroxetine Hcl	11	suppressed
Santyl	Collagenase Clostridium Hist.	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error